-
Evidence-Based Risk Factors for Failure of Arthroscopic Labral Repair
-
Beach Chair Versus Lateral Decubitus Surgical Positioning for Arthroscopic Shoulder Stabilization Surgery: What Does The Evidence Say?
-
Artificial Intelligence and its Current Role in Clinical Outcome Prediction, Musculoskeletal Imaging, and Economic and Ethical Considerations within Orthopedics and Sports Medicine
-
Guillain-Barré Syndrome, Subtype AMAN, Can Only Be Attributed to Lupus Erythematosus if All Infectious Causes Have Been Ruled Out [Letter]
-
Guillain-Barré Syndrome, Subtype AMAN, Can Only Be Attributed to Lupus Erythematosus if All Infectious Causes Have Been Ruled Out [Response to Letter]
-
Management and Outcomes of Osteochondritis Dissecans of the Knee in the Pediatric and Adolescent Population
-
Pregnancy outcomes in patients with axial spondyloarthritis: a UK-based survey
-
A Review and Future Perspective on Renal Outcome Definitions in Lupus Nephritis
-
Variation in the feasibility and acceptability of electronic patient-reported outcome measures in patients with inflammatory arthritis
-
Characterizing Adherence to a Mobile Health App for Patient-Reported Outcomes in Rheumatoid Arthritis
-
Hip Arthroscopy After Total Hip Arthroplasty: A Current Review of Indications, Techniques, and Outcomes
-
Correction to: Hip Arthroscopy After Total Hip Arthroplasty: A Current Review of Indications, Techniques, and Outcomes
-
Treatment Patterns and Outcomes of Acthar Gel in Ankylosing Spondylitis and Psoriatic Arthritis: A Physician-Reported Chart Review
-
Impact of biological/targeted versus conventional synthetic disease‐modifying antirheumatic drugs on patient‐reported outcomes in rheumatoid arthritis
-
Real-World Upadacitinib Persistence and Clinical Outcomes Among Canadian Patients with Inflammatory Arthritis from a Patient Support Program: The UPRAISE Study
-
Duration of Belimumab Therapy and Timing of Initiation as Predictors of Clinical Outcomes in Childhood-Onset Systemic Lupus Erythematosus: A Real-World Retrospective Study
-
Olokizumab Improves Patient-Reported Outcomes in Patients with Active Rheumatoid Arthritis up to 106 Weeks (Results from the Open-Label Extension of Phase III Randomized Clinical Trials)
-
An Exploratory Analysis of Antibody Dynamics in Isolated Organ Involvement of Antisynthetase Syndrome: A Single‐Center Experience
-
Issue Information
-
Successful Treatment of Anti-Jo-1 Positive Inflammatory Myopathy With Tofacitinib
-
A Case of Neural Tube Defect in Early Pregnancy Following Sulfasalazine Exposure Without Folic Acid Supplementation
-
Case Report: Secukinumab Experience in a Patient With Coexistence of Systemic Lupus Erythematosus, Ankylosing Spondylitis, and Antiphospholipid Antibody Syndrome
-
Thymoma-Associated Systemic Lupus Erythematosus and Myasthenia Gravis
-
Pericarditis as the Initial Manifestation of Antisynthetase Syndrome: A Case Report
